19/12/2014 22:41:36 Free Membership Login

   

Atherogenics

Visual Financials
Company Name: AtheroGenics, Incorporated
Ticker Symbol: AGIX
WWW Address: www.AtheroGenics.com
CEO: Dr. Russell M. Medford, M.D., Ph.D.
No. of Employees: 57
Common Issue Type: CS
Business Description:A pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including diabetes and coronary heart disease.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 0.07 Unchanged 0.0 - -  0.09 0.05 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 0.0 0.0 0.00  0.00 0.0 0.0 0.07 - 0.07
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close0.07$
PE Ratio - LTM0.0
Market Capitalisation0.0mil
Latest Shares Outstanding0.0mil
Earnings pS (EPS)$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float0.0mil
Float as % of Shares Outstanding%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.00$
Cash pS0.00$
Book-Value pS$
Tangible Book-Value pS0.00$
Cash Flow pS$
Free Cash Flow pS$
KEY FIGURES (LTM): Price info
Price/Book Ratio
Price/Tangible Book Ratio0.00
Price/Cash Flow
Price/Free Cash Flow
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---0.07-100
4 Weeks0.090.050.050.07
13 Weeks0.070.07184850.07
26 Weeks184850.07
52 Weeks0.07
YTD0.070.07-0.07-100-100
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
0.050.05
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue
Income
Dividend
Capital SpendingNA
R&DNA
Normalized Inc.NA
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %142424
Earnings %7727
EPS %62020
EPS $273030
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio103139028
Quick Ratio (Acid Test)6338926
Liquidity Ratio (Cash)0.00
Receivables Turnover
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS-195594625
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)781119
Debt Ratio
Total Debt/Equity (Gearing Ratio)C
LT Debt/Equity
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities
Interest Cover6765289
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA-0.00
Enterprise Value (EV)/Free Cash Flow101.25
Dividend Yield
Price/Tangible Book Ratio - LTM14
Price/Book Ratio - LTM
Price/Cash Flow Ratio
Price/Free Cash Flow Ratio - LTM14
Price/Sales Ratio23.00
P/E Ratio (1 month ago) - LTM
P/E Ratio (26 weeks ago) - LTM
P/E Ratio (52 weeks ago) - LTM
5-Y High P/E Ratio
5-Y Low P/E Ratio
5-Y Average P/E Ratio
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM
Book Value pS - LTM
Capital Invested pS0.00
Cash pS - LTM129
Cash Flow pS - LTM4.68
Free Cash Flow pS - LTM4.68
Earnings pS (EPS)-100
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin6765289
Net Profit Margin - 5YEAR AVRG.
Equity Productivity0.00
Return on Equity (ROE)-195594625
Return on Equity (ROE) - 5YEAR AVRG.
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.
Assets Productivity781,119.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.
Gross Profit Margin
Gross Profit Margin - 5YEAR AVRG.
EBITDA Margin - LTM
EBIT Margin - LTM
Pre-Tax Profit Margin9126342
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle46,570,839
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover
Day's Inventory Turnover Ratio46570551
Inventory Turnover
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover781119
Revenue per $ Cash
Revenue per $ Plant
Revenue per $ Common Equity9820682
Revenue per $ Capital Invested9820682
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq agix141219 22:41